Clinical Trial Update: Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA) [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding study evaluating namilumab in combination with methotrexate for moderate to severe rheumatoid arthritis has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Namilumab (namilumab)

Snippet

Sponsor: Takeda | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2018-09-14